A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains
Abstract Background Daptomycin is an important drug used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection. A high dose of daptomycin is indicated for an MRSA infection with a minimum inhibitory concentration (MIC) of 1 mg/L for daptomycin. Combination therapies with d...
Main Authors: | Yi-Chien Lee, Pao-Yu Chen, Jann-Tay Wang, Shan-Chwen Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-019-0305-y |
Similar Items
-
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
by: Taylor Morrisette, et al.
Published: (2020-10-01) -
Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
by: Melanie Roch, et al.
Published: (2017-12-01) -
Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
by: Feng-Jui Chen, et al.
Published: (2018-05-01) -
Daptomycin for the treatment of infective endocarditis: When do we use it?
by: Serap Şimşek Yavuz
Published: (2017-06-01) -
The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022-12-01)